MemoHoney Reviews: Once-Daily Capsule With a Fully Disclosed Seven-Ingredient Label Enters the U.S. Cognitive Supplement Market

Memo Honey announces U.S. availability of a once-daily capsule built on nitric oxide precursor amino acids, with every ingredient amount individually disclosed and no proprietary blend.

MemoHoney is a once-daily capsule containing seven disclosed ingredients: niacin, calcium, two forms of L-arginine, two forms of L-citrulline and beta-alanine. Every active carries an individual amount on the supplement facts panel, with no proprietary blend. It is available in two-, three- and six-bottle configurations, with 30 capsules per bottle.

OGDEN, Utah, August 14, 2026 — The formula is built primarily on the nitric oxide pathway. L-arginine is the substrate from which nitric oxide synthase produces nitric oxide; L-citrulline is converted to arginine in the kidney and reaches the pathway indirectly. These are the same amino acids studied extensively in vascular research, and the manufacturer positions them here for cerebral blood flow rather than for peripheral circulation.

That positioning is worth stating plainly at the outset, because it determines how the research below should be read. Most published trials of these amino acids measured vascular endpoints — blood pressure, arterial stiffness, endothelial function — rather than memory or cognition. The cognitive literature on them is smaller, more recent, and conducted in specific populations. This release reports both, and identifies which is which.

→ Product information, the full supplement facts panel and current package options are published at globenewstoday.com/recommends/memohoney/

Product Overview

Memo Honey is a capsule dietary supplement supplied in bottles of 30 capsules at 30 servings per container, a one-month supply at the labeled serving of one capsule daily.

The supplement facts panel declares an individual amount for every active ingredient, with no proprietary blend. This is uncommon in the cognitive supplement category and it is the practical difference for a buyer: under 21 CFR 101.36, U.S. manufacturers may group ingredients and declare only a combined weight, which makes comparison against published research impossible. Memo Honey does not use that provision, so the comparison can be made — and this release makes it, ingredient by ingredient, below.

The panel lists niacin at 7.5 mg NE, or 47 percent of the daily value, and calcium as calcium carbonate at 18 mg, or 1.5 percent of the daily value. Five amino acid ingredients follow: L-arginine base at 200 mg, L-arginine AKG 2:1 extract at 200 mg, L-citrulline HCl at 100 mg, L-citrulline malate at 100 mg, and beta-alanine at 40 mg. Other ingredients are hypromellose (the vegetable capsule shell), vegetable stearate and silicon dioxide.

Two points on how those figures should be read. The arginine and citrulline entries are salts or conjugates rather than free amino acids, so the declared weights exceed the free amino acid content by an amount the label does not specify — the AKG 2:1 designation indicates two arginine molecules bound to one alpha-ketoglutarate, and the malate and HCl forms similarly include a non-amino-acid fraction. And the calcium figure at 1.5 percent of the daily value is nutritionally negligible; at 18 mg it contributes little toward the 1,000 to 1,200 mg adult requirement and is present at a level more consistent with a processing aid than an active.

The label directs users to take one capsule daily with an 8 oz. glass of water, and for best results 20 to 30 minutes before a meal or as directed by a healthcare professional. The front panel describes the product as advanced memory support and carries the FDA disclaimer footnote reproduced at the end of this release.

Statement from the Company

“We made a decision early that every amount would be disclosed. Proprietary blends are legal and common in this category, and they also make it impossible for a buyer to check what they are actually taking against what has been studied. We would rather publish the numbers. We want to be equally direct about what those numbers mean: the amounts here are lower than the doses used in the research behind these ingredients, and that difference is stated in this release rather than left for someone to discover. MemoHoney is a dietary supplement. It is not a treatment for memory loss or for any cognitive condition, and anyone experiencing memory changes should see a physician rather than reach for a supplement.”

— MemoHoney Product Development Team, Instituto Experience

Ingredient Research

The following section describes the ingredients as stated on the supplement facts panel, each accompanied by independently published research.

Important qualification: all citations below describe research conducted under conditions unaffiliated with MemoHoney, in every case at doses substantially higher than the amounts on this label, and where that is so it is stated alongside the citation. These citations establish that these ingredients have been studied. They do not constitute clinical evidence that MemoHoney produces equivalent outcomes, and no such equivalence is claimed.

L-arginine, 400 mg across two forms. The direct substrate for nitric oxide synthase. The most relevant cognitive study is a placebo-controlled clinical trial published in Frontiers in Cardiovascular Medicine (Gambardella, J., et al., 2022, “L-arginine improves cognitive impairment in hypertensive frail older adults,” doi:10.3389/fcvm.2022.868521), which randomized 72 frail hypertensive patients over 65 with Montreal Cognitive Assessment scores below 26 to L-arginine or placebo for four weeks and reported improvement in global cognitive function. Three features of that trial bear on interpretation. The dose was 1.66 g twice daily, a total of 3.32 g per day — roughly ten times the arginine content of one MemoHoney capsule before accounting for the salt fraction. The population was frail, hypertensive and already cognitively impaired, not healthy adults. And the trial ran four weeks in a single Italian health unit. A more recent randomized placebo-controlled pilot study in older adults with cognitive complaints has been published in Cureus (2025), also at gram-level dosing.

L-citrulline, 200 mg across two forms. Converted to arginine in the kidney and studied as an indirect route to raising nitric oxide availability. The published trial evidence for citrulline concerns vascular rather than cognitive endpoints. A systematic review and meta-analysis in Nutrition & Metabolism (Zhu, X., et al., 2019, “Effect of oral L-citrulline on brachial and aortic blood pressure defined by resting status,” doi:10.1186/s12986-019-0415-y) pooled fourteen trials and reported reductions in brachial systolic and diastolic blood pressure, with the reviewers noting that the small number of trials meant the findings should be interpreted cautiously. Trials in this literature use oral citrulline at 3 to 10 g daily. No comparable body of randomized cognitive-endpoint evidence exists for citrulline, and none is cited here because none would support such a claim.

Beta-alanine, 40 mg. A precursor to carnosine, a dipeptide studied primarily in exercise physiology as an intracellular pH buffer. The direct cognitive evidence is negative. A study published in PLOS ONE (Blancquaert, L., et al., 2015, “Effects of beta-alanine supplementation on brain homocarnosine/carnosine signal and cognitive function: an exploratory study,” doi:10.1371/journal.pone.0123857) supplemented participants with 6.4 g daily for 28 days and found no effect on brain homocarnosine/carnosine signal in either omnivores or vegetarians, and no effect on response times or accuracy across the Stroop test, Sternberg paradigm or Rapid Visual Information Processing task, at rest or after exercise. The International Society of Sports Nutrition position stand on beta-alanine identifies 4 to 6 g daily for at least four weeks as the range at which muscle carnosine concentrations are meaningfully augmented. The 40 mg in this product is under 1 percent of that range, and this is the largest proportional gap between a labeled amount and a studied dose anywhere in this formula.

Niacin (vitamin B3), 7.5 mg NE. An essential vitamin and a precursor of NAD and NADP, coenzymes required across cellular energy metabolism including in neurons. The recommended dietary allowance is 16 mg NE daily for adult men and 14 mg NE for adult women (Niacin Fact Sheet for Health Professionals, NIH Office of Dietary Supplements; ods.od.nih.gov). The 7.5 mg NE here represents 47 percent of the daily value and falls below the RDA, so it is a partial contribution to daily requirement rather than a supplemental dose above it. Severe niacin deficiency causes pellagra, whose classical presentation includes cognitive decline, and correcting that deficiency resolves the neurological symptoms — but pellagra is rare in industrialized countries, and the relationship between deficiency and cognition should not be read as evidence that intake at or below the RDA improves memory in adequately nourished adults. Observational work has examined dietary niacin intake against incident Alzheimer disease (Morris, M.C., et al., 2004, Journal of Neurology, Neurosurgery and Psychiatry, 75(8):1093–1099; PMID 15258207); observational data of this kind describes associations and cannot establish that supplementation changes outcomes.

Calcium (as calcium carbonate), 18 mg. At 1.5 percent of the daily value, this amount is nutritionally negligible against an adult requirement of 1,000 to 1,200 mg daily. No research is cited for it because the amount present would not be expected to produce a nutritional effect.

What the Evidence Base Does and Does Not Show

Full disclosure benefits a buyer only if the disclosed figures are placed next to the figures used in research. Doing that here produces a consistent picture rather than a mixed one: every active ingredient is present at a fraction of its studied dose.

Arginine is at roughly a tenth of the dose used in the one cognitive trial cited, before accounting for the salt fraction. Citrulline is at a small fraction of the 3 to 10 g used in vascular trials, and has no comparable cognitive trial literature at any dose. Beta-alanine is under 1 percent of the range the sports nutrition literature identifies as effective, and the one study that tested beta-alanine against cognitive endpoints found no effect even at 6.4 g daily. Niacin falls below the recommended dietary allowance. Calcium is nutritionally negligible.

A second distinction matters as much as dose. Most of the research behind these amino acids measured vascular outcomes, not memory. The proposition that improving cerebral blood flow improves memory in healthy adults is plausible as a mechanism and is not established as an outcome; the one cognitive trial cited studied frail, hypertensive, already-impaired older patients at ten times this dose over four weeks.

Ingredient research is a reason to examine a formula. It is not a substitute for testing the formula itself, and no published clinical trial has evaluated MemoHoney as sold.

Format and Daily Use

MemoHoney is positioned as a nutritional addition to an established routine, not a replacement for any part of one. Sleep, physical activity, cardiovascular health, hearing, social engagement, education and management of conditions such as hypertension and diabetes are the factors with the strongest evidence base in cognitive aging, and individual experience varies with all of them.

Memory change is a clinical matter. Anyone experiencing new or worsening memory difficulty, confusion, disorientation, difficulty with familiar tasks, or changes in language or personality should seek evaluation from a physician rather than a dietary supplement. Several causes of cognitive symptoms — including thyroid dysfunction, vitamin B12 deficiency, medication effects, depression and sleep disorders — are identifiable and treatable, and identifying them requires a clinical assessment.

Market Context

The label and public nutrition data provide the verifiable backdrop for this category. Niacin requirements are established at 16 mg NE daily for adult men and 14 mg NE for adult women by the Food and Nutrition Board, as published by the NIH Office of Dietary Supplements, and niacin is widely present in meat, fish, poultry, legumes, nuts and enriched grains, with many animal-based foods providing 5 to 10 mg per serving. Calcium requirements for adults are set at 1,000 to 1,200 mg daily. Those figures allow a reader to place this product’s vitamin and mineral content in context without reference to any commercial estimate.

No third-party market sizing figure for the cognitive supplement category is cited in this release, because the available estimates vary by an order of magnitude depending on whether they count nootropics, brain health supplements, or the broader memory and focus category, and quoting any one of them would suggest a precision the category does not have.

Availability and Pricing

MemoHoney is sold through the manufacturer’s authorized retail portal. Three package configurations are listed at the time of this release:

• Two bottles (60-day supply) at $79 per bottle, $158 total, plus shipping

• Three bottles (90-day supply) at $69 per bottle, $207 total, with free U.S. shipping

• Six bottles (180-day supply) at $49 per bottle, $294 total, with free U.S. shipping

No single-bottle configuration is offered. At 30 capsules per bottle and the labeled serving of one capsule daily, each bottle covers 30 days, so the stated supply durations are consistent with the labeled serving. All purchases are a one-time charge with no subscription or auto-ship enrollment applied by default. Pricing and promotional terms are set by the seller and subject to change; buyers should confirm current terms at checkout rather than relying on any third-party description, including this one.

Orders are covered by a 60-day money-back guarantee. Buyers should note that the seller’s published terms describe the guarantee as unconditional and running 60 days from purchase while also referring to a minimum of 30 days of use before a refund request. Anyone relying on the guarantee should confirm the exact conditions with the seller in writing before ordering, and should retain their order confirmation and return instructions.

→ Current package options, pricing and guarantee terms are listed at globenewstoday.com/recommends/memohoney/

Quality and Manufacturing

The label states that MemoHoney is manufactured in the USA with globally sourced ingredients. The label reviewed for this release does not name a manufacturing facility, does not carry an FDA-registration or GMP-certification statement, and no certificate of analysis or third-party testing record was published on the pages reviewed. Buyers wanting that documentation should request it from the distributor.

Under 21 CFR Part 111, dietary supplement manufacturers are required to comply with current Good Manufacturing Practice regulations covering production standards, ingredient identity testing, quality control and accurate labeling, whether or not a claim to that effect appears on a label. No dietary supplement is approved by the FDA before marketing, and FDA registration of a facility, where it exists, is a filing requirement rather than an endorsement or evaluation of any product made there.

The label identifies Instituto Experience, of Ogden, Utah, as the distributor, listing a post office box address.

Usage Guidance and Safety Information

MemoHoney is intended for adult use. The label directs users to take one capsule daily with an 8 oz. glass of water, not to exceed the recommended dose, and to store the product in a cool, dry place away from heat and light. It states that the product is not for children under 18, and that pregnant or nursing mothers and individuals with a known medical condition should consult a physician before use.

This product is not a treatment for memory loss, dementia, Alzheimer disease or any cognitive condition, and no statement in this release should be read as suggesting otherwise. Anyone taking prescribed medication for a cognitive or neurological condition should not stop, reduce or delay it on the basis of a dietary supplement.

Arginine and citrulline act on the nitric oxide pathway, which is also the pathway targeted by several classes of medication. Anyone taking blood pressure medication, nitrates, or PDE5 inhibitors such as sildenafil, tadalafil or vardenafil should consult a prescriber before use, because of the possibility of additive blood-pressure lowering. Anyone taking anticoagulant or antiplatelet medication should do the same.

Individuals with established cardiovascular disease or a history of myocardial infarction should consult a physician before using an arginine-containing product. A randomized trial of L-arginine at 9 g daily following a first heart attack (Schulman, S.P., et al., 2006, JAMA, 295(1):58–64; PMID 16391217) was terminated early after higher mortality was observed in the L-arginine group, concentrated among patients age 60 and older. That dose is many times the amount in this product and the population was patients recovering from a recent infarction, but the finding exists and is relevant to anyone in that group evaluating an arginine supplement.

Beta-alanine causes paraesthesia, a transient tingling sensation, at the gram-level doses used in exercise research; it would not be expected at 40 mg. Niacin at pharmacological doses causes flushing; the amount here is a nutritional dose below the RDA and flushing would not be expected.

Individual results vary. This product is not a substitute for professional medical care and is not a treatment for any medical condition.

Scope of This Announcement

This is a product availability announcement, not a clinical trial report, an efficacy claim or an independent product evaluation. No peer-reviewed trial of the finished MemoHoney formula is cited, because the research referenced here concerns individual ingredients rather than the assembled product.

Three points bear on any evaluation. Every active ingredient is present at a fraction of the dose used in the research cited, stated ingredient by ingredient above. Most of that research measured vascular rather than cognitive endpoints, and the one direct cognitive test of beta-alanine returned a null result at 160 times this product’s amount. And the refund guarantee applies to the authorized retail portal; third-party listings may not carry the same terms.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Affiliate Disclosure: This press release contains a link to a retail partner website through which the distributor may receive compensation if a purchase is made following a referral, disclosed in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The affiliate relationship does not influence the factual content of this release. No compensation was provided to any researcher, journal or institution cited above, and no citation should be read as an endorsement of this product by its authors or publisher. This release is informational, is based on the product label combined with published research on the individual ingredients, and does not constitute medical advice, diagnosis or treatment. Readers experiencing memory or cognitive changes should seek evaluation from a licensed physician.

About MemoHoney

MemoHoney is a dietary supplement brand distributing a once-daily capsule containing niacin, calcium, L-arginine base, L-arginine AKG 2:1 extract, L-citrulline HCl, L-citrulline malate and beta-alanine, supplied in 30-capsule bottles. Every active ingredient is disclosed with an individual amount on the supplement facts panel, and the formula contains no proprietary blend. The product is manufactured in the USA with globally sourced ingredients and distributed by Instituto Experience of Ogden, Utah, with a 60-day money-back guarantee. MemoHoney is a dietary supplement and is not intended to diagnose, treat, cure or prevent any disease.

Media Contact

Kevin Shaw, MemoHoney Product Support, Instituto Experience

Email : contact@mymemohoney.com

Phone: +1 (855) 889-3137

Website : https://mymemohoney.com

Address: Instituto Experience, PO Box 12730, Ogden, UT 84404, USA

For more press release distribution and guest post services, visit TS Newswire.